Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approach.

Nikolsky E, Mehran R, Dangas G, Fahy M, Na Y, Pocock SJ, Lincoff AM, Stone GW.

Eur Heart J. 2007 Aug;28(16):1936-45. Epub 2007 Jun 15.

PMID:
17575270
2.

Major bleeding complicating contemporary primary percutaneous coronary interventions-incidence, predictors, and prognostic implications.

Fuchs S, Kornowski R, Teplitsky I, Brosh D, Lev E, Vaknin-Assa H, Ben-Dor I, Iakobishvili Z, Rechavia E, Battler A, Assali A.

Cardiovasc Revasc Med. 2009 Apr-Jun;10(2):88-93. doi: 10.1016/j.carrev.2008.08.001.

PMID:
19327670
3.

A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation.

Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, Mintz GS, Lansky AJ, Moses JW, Stone GW, Leon MB, Dangas G.

J Am Coll Cardiol. 2004 Oct 6;44(7):1393-9.

4.

Incremental Value of Platelet Reactivity Over a Risk Score of Clinical and Procedural Variables in Predicting Bleeding After Percutaneous Coronary Intervention via the Femoral Approach: Development and Validation of a New Bleeding Risk Score.

Mangiacapra F, Ricottini E, Barbato E, Demartini C, Peace A, Patti G, Vizzi V, De Bruyne B, Wijns W, Di Sciascio G.

Circ Cardiovasc Interv. 2015 May;8(5). pii: e002106. doi: 10.1161/CIRCINTERVENTIONS.114.002106.

5.

Incidence, predictors, and clinical impact of bleeding after transradial coronary stenting and maximal antiplatelet therapy.

Bertrand OF, Larose E, Rodés-Cabau J, Gleeton O, Taillon I, Roy L, Poirier P, Costerousse O, Larochellière RD.

Am Heart J. 2009 Jan;157(1):164-9. doi: 10.1016/j.ahj.2008.09.010. Epub 2008 Nov 6.

PMID:
19081414
6.

Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions.

Kinnaird TD, Stabile E, Mintz GS, Lee CW, Canos DA, Gevorkian N, Pinnow EE, Kent KM, Pichard AD, Satler LF, Weissman NJ, Lindsay J, Fuchs S.

Am J Cardiol. 2003 Oct 15;92(8):930-5.

PMID:
14556868
7.

Body mass index, periprocedural bleeding, and outcome following percutaneous coronary intervention (from the British Columbia Cardiac Registry).

Byrne J, Spence MS, Fretz E, Mildenberger R, Chase A, Berry B, Pi D, Janssen C, Klinke P, Hilton D.

Am J Cardiol. 2009 Feb 15;103(4):507-11. doi: 10.1016/j.amjcard.2008.10.027.

PMID:
19195511
8.

Predicting major adverse cardiac events after percutaneous coronary intervention: the Texas Heart Institute risk score.

Madan P, Elayda MA, Lee VV, Wilson JM.

Am Heart J. 2008 Jun;155(6):1068-74. doi: 10.1016/j.ahj.2008.01.034. Epub 2008 Apr 3.

PMID:
18513521
9.

Development and validation of a bleeding risk model for patients undergoing elective percutaneous coronary intervention.

Montalescot G, Salette G, Steg G, Cohen M, White HD, Gallo R, Steinhubl SR.

Int J Cardiol. 2011 Jul 1;150(1):79-83. doi: 10.1016/j.ijcard.2010.02.077. Epub 2010 Mar 17.

PMID:
20299114
10.

Risk factors for the development of retroperitoneal hematoma after percutaneous coronary intervention in the era of glycoprotein IIb/IIIa inhibitors and vascular closure devices.

Farouque HM, Tremmel JA, Raissi Shabari F, Aggarwal M, Fearon WF, Ng MK, Rezaee M, Yeung AC, Lee DP.

J Am Coll Cardiol. 2005 Feb 1;45(3):363-8.

11.

Incidence, predictors, and prognostic implications of hospitalization for late bleeding after percutaneous coronary intervention for patients older than 65 years.

Ko DT, Yun L, Wijeysundera HC, Jackevicius CA, Rao SV, Austin PC, Marquis JF, Tu JV.

Circ Cardiovasc Interv. 2010 Apr;3(2):140-7. doi: 10.1161/CIRCINTERVENTIONS.109.928721. Epub 2010 Mar 23.

12.

Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification.

Bartholomew BA, Harjai KJ, Dukkipati S, Boura JA, Yerkey MW, Glazier S, Grines CL, O'Neill WW.

Am J Cardiol. 2004 Jun 15;93(12):1515-9.

PMID:
15194023
13.

Simplified risk score models accurately predict the risk of major in-hospital complications following percutaneous coronary intervention.

Resnic FS, Ohno-Machado L, Selwyn A, Simon DI, Popma JJ.

Am J Cardiol. 2001 Jul 1;88(1):5-9.

PMID:
11423050
14.
15.

A novel percutaneous coronary intervention risk score to predict one-year mortality.

Maluenda G, Delhaye C, Gaglia MA Jr, Ben-Dor I, Gonzalez MA, Hanna NN, Collins SD, Wakabayashi K, Torguson R, Xue Z, Satler LF, Pichard AD, Waksman R.

Am J Cardiol. 2010 Sep 1;106(5):641-5. doi: 10.1016/j.amjcard.2010.04.011.

PMID:
20723638
16.

Haematoma after coronary angiography and percutaneous coronary intervention via the femoral artery frequency and risk factors.

Andersen K, Bregendahl M, Kaestel H, Skriver M, Ravkilde J.

Eur J Cardiovasc Nurs. 2005 Jun;4(2):123-7.

PMID:
15869905
18.

Validation of the Mayo clinic risk score for in-hospital mortality after percutaneous coronary interventions using the national cardiovascular data registry.

Singh M, Peterson ED, Milford-Beland S, Rumsfeld JS, Spertus JA.

Circ Cardiovasc Interv. 2008 Aug;1(1):36-44. doi: 10.1161/CIRCINTERVENTIONS.107.755991.

19.

Effectiveness of the transradial approach to reduce bleedings in patients undergoing urgent coronary angioplasty with GPIIb/IIIa inhibitors for acute coronary syndromes.

De Carlo M, Borelli G, Gistri R, Ciabatti N, Mazzoni A, Arena M, Petronio AS.

Catheter Cardiovasc Interv. 2009 Sep 1;74(3):408-15. doi: 10.1002/ccd.22008.

PMID:
19360863
20.

Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis.

Ruiz-Nodar JM, Marín F, Hurtado JA, Valencia J, Pinar E, Pineda J, Gimeno JR, Sogorb F, Valdés M, Lip GY.

J Am Coll Cardiol. 2008 Feb 26;51(8):818-25. doi: 10.1016/j.jacc.2007.11.035.

Supplemental Content

Support Center